JP2009524051A5 - - Google Patents

Download PDF

Info

Publication number
JP2009524051A5
JP2009524051A5 JP2008551261A JP2008551261A JP2009524051A5 JP 2009524051 A5 JP2009524051 A5 JP 2009524051A5 JP 2008551261 A JP2008551261 A JP 2008551261A JP 2008551261 A JP2008551261 A JP 2008551261A JP 2009524051 A5 JP2009524051 A5 JP 2009524051A5
Authority
JP
Japan
Prior art keywords
hoxa5
calm
test compound
leukemia
dot1l
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008551261A
Other languages
English (en)
Japanese (ja)
Other versions
JP5167149B2 (ja
JP2009524051A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/046612 external-priority patent/WO2007087015A1/en
Publication of JP2009524051A publication Critical patent/JP2009524051A/ja
Publication of JP2009524051A5 publication Critical patent/JP2009524051A5/ja
Application granted granted Critical
Publication of JP5167149B2 publication Critical patent/JP5167149B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008551261A 2006-01-20 2006-12-06 白血病の診断および治療ターゲット Expired - Fee Related JP5167149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76070906P 2006-01-20 2006-01-20
US60/760,709 2006-01-20
PCT/US2006/046612 WO2007087015A1 (en) 2006-01-20 2006-12-06 Diagnostic and therapeutic targets for leukemia

Publications (3)

Publication Number Publication Date
JP2009524051A JP2009524051A (ja) 2009-06-25
JP2009524051A5 true JP2009524051A5 (https=) 2010-01-28
JP5167149B2 JP5167149B2 (ja) 2013-03-21

Family

ID=38309541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008551261A Expired - Fee Related JP5167149B2 (ja) 2006-01-20 2006-12-06 白血病の診断および治療ターゲット

Country Status (6)

Country Link
US (2) US8524467B2 (https=)
EP (2) EP1974055A4 (https=)
JP (1) JP5167149B2 (https=)
AU (1) AU2006336552B2 (https=)
CA (1) CA2623271A1 (https=)
WO (1) WO2007087015A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102477A1 (en) 2010-06-23 2013-04-25 Ryan D. Morin Biomarkers for non-hodgkin lymphomas and uses thereof
US9175331B2 (en) 2010-09-10 2015-11-03 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
BR112013005806B1 (pt) 2010-09-10 2022-05-10 Epizyme, Inc Métodos para detectar se um indivíduo é um candidato para o tratamento com ou responsivo a um inibidor de ezh2 e usos terapêuticos do dito inibidor de ezh2
TWI598336B (zh) 2011-04-13 2017-09-11 雅酶股份有限公司 經取代之苯化合物
JO3363B1 (ar) 2011-04-13 2019-03-13 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
PT3184523T (pt) 2012-04-13 2019-09-26 Eisai R&D Man Co Ltd Bromidrato de n-((4,6-dimetil-2-oxo-l,2-di-hidropiridin- 3-il)metil)-5-(etil(tetra-hidro-2h-piran-4-il)amino)-4- metil-4¿-(morfolinometil)-[l,1¿-bofenil]-3-carboxamida para utilização no tratamento de uma doença proliferativa celular do sistema hematológico
MX2015004721A (es) 2012-10-15 2016-01-25 Epizyme Inc Compuestos de benceno sustituidos.
CA2920252A1 (en) * 2013-08-02 2015-02-05 Memorial Sloan-Kettering Cancer Center Methods for the detection and treatment of leukemias that are responsive to dot1l inhibition
MA38949A1 (fr) 2013-10-16 2017-07-31 Eisai R&D Man Co Ltd Forme saline d'hydrochlorure pour inhibition d'ezh2
WO2020150326A1 (en) * 2019-01-15 2020-07-23 Ptc Therapeutics, Inc. Method for treating an acute myeloid leukemia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420328A (en) 1992-09-11 1995-05-30 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5525734A (en) 1994-06-22 1996-06-11 Affymax Technologies N.V. Methods for synthesizing diverse collections of pyrrolidine compounds
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5817751A (en) 1994-06-23 1998-10-06 Affymax Technologies N.V. Method for synthesis of diketopiperazine and diketomorpholine derivatives
US6251594B1 (en) * 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
US6555329B2 (en) * 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
AU2002329784A1 (en) 2001-08-17 2003-03-03 Incyte Genomics, Inc. Molecules for disease detection and treatment
US7485414B2 (en) * 2002-08-30 2009-02-03 Rigel Pharmaceuticals, Inc. Modulators of angiogenesis
US7442685B2 (en) 2003-06-13 2008-10-28 The University Of North Carolina At Chapel Hill DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
DE602004023766D1 (de) 2004-08-31 2009-12-03 Univ North Carolina Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie

Similar Documents

Publication Publication Date Title
JP6523375B2 (ja) 肝臓病変を評価する方法
JP2008546403A5 (https=)
JP2010518848A5 (https=)
RU2014123511A (ru) Способы лечения, диагностики и мониторинга болезни альцгеймера
KR20100058421A (ko) 신규 발병 심부전증에 대한 개별 위험 평가용 전사체 바이오마커
JP2008509673A5 (https=)
JP2012501452A5 (https=)
WO2012107580A1 (en) In vitro diagnosis method for predicting a predisposition to cardiomyopathy
JP2009524051A5 (https=)
Chinault et al. Application of dual-genome oligonucleotidearray-based comparative genomic hybridization to the molecular diagnosis of mitochondrial DNA deletion and depletion syndromes
EP4190915A1 (en) Biomarker for diagnosing nonalcoholic steatohepatitis using microrna combination
JP2008512984A5 (https=)
JP2019507594A (ja) 大腸がん診断用組成物と診断マーカー検出方法
US10519507B2 (en) Method for detecting T-cell lymphoma
JP2017176186A (ja) 線維症感受性il22ra2遺伝子およびその使用
WO2009099941A2 (en) Sequences associated with tdp-43 proteinopathies and methods of using the same
JP2008547006A5 (https=)
WO2024102976A1 (en) Molecular signatures to predict long-term liver fibrosis progression
US20240410005A1 (en) Methods for predicting drug responsiveness in heart failure subjects
CN111808961B (zh) 一种用于检测肝癌的生物标志物组及其应用
JP2024519975A (ja) フラグメントミクスを用いてがんを検出するための方法および組成物
JP2006526986A (ja) 炎症性大腸炎の診断方法
EP2716767A1 (en) Method for determining the prognosis of pancreatic cancer
EP2669384B1 (en) Method for evaluating the presence of rheumatoid arthritis and biomarker set used in the same
JP2010501162A5 (https=)